CVS Health Sees Unusually High Options Volume (NYSE:CVS)

CVS Health Corporation (NYSE:CVS) was the recipient of unusually large options trading activity on Wednesday. Traders bought 37,560 call options on the company. This is an increase of approximately 59% compared to the typical volume of 23,606 call options.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. SOA Wealth Advisors LLC. grew its stake in shares of CVS Health by 36.9% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after buying an additional 131 shares in the last quarter. Alteri Wealth LLC raised its position in CVS Health by 3.2% during the third quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock valued at $316,000 after acquiring an additional 131 shares in the last quarter. TOWER TRUST & INVESTMENT Co lifted its stake in CVS Health by 0.8% in the fourth quarter. TOWER TRUST & INVESTMENT Co now owns 15,708 shares of the pharmacy operator’s stock valued at $1,247,000 after acquiring an additional 132 shares during the last quarter. Holistic Financial Partners grew its position in CVS Health by 4.1% in the third quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock worth $256,000 after acquiring an additional 133 shares in the last quarter. Finally, CYBER HORNET ETFs LLC increased its stake in shares of CVS Health by 4.1% during the 3rd quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock worth $259,000 after purchasing an additional 134 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Up 1.7%

Shares of NYSE:CVS opened at $81.49 on Thursday. The firm has a market cap of $103.44 billion, a P/E ratio of 214.44, a P/E/G ratio of 0.74 and a beta of 0.48. CVS Health has a 12-month low of $52.34 and a 12-month high of $85.15. The business has a fifty day simple moving average of $78.88 and a 200 day simple moving average of $74.56. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Analysts predict that CVS Health will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. CVS Health’s dividend payout ratio is 700.00%.

Analyst Upgrades and Downgrades

Several brokerages recently commented on CVS. Mizuho increased their price objective on shares of CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. The Goldman Sachs Group increased their price target on CVS Health from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, December 10th. Robert W. Baird boosted their price objective on CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $101.00 target price (up previously from $99.00) on shares of CVS Health in a report on Wednesday, December 10th. Nineteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $94.86.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.